Internal medicine - 1 News from the business & finance department by Chugai Pharmaceutical for the pharma industry

Internal medicine - 1 News from the business & finance department by Chugai Pharmaceutical for the pharma industry

image description

Araris Biotech announces research collaboration and option to license agreement with Chugai Pharmaceutical Co.

Araris to receive an upfront fee and milestone payments potentially totalling USD 780 million plus royalties on net product sales

15-Jan-2025 - Araris Biotech AG, a Swiss oncology biotech spin-off company developing next-generation antibody drug conjugates (ADCs), announced they have entered a Research Collaboration and Option to License Agreement (“RCO”) under which Araris will use its proprietary linker-conjugation platform, AraLinQ™, ...

internal medicine antibodies antibody-drug conjugates

These products might interest you

fully automated Askion FluoM® New

fully automated Askion FluoM® by Askion

Fully automated fluorescence microscope: precise, efficient and flexible for every application

Individually configurable, high throughput rate and versatile in research and diagnostics

fluorescence microscopes
View product
Askion FluoS®

Askion FluoS® by Askion

Automated Fluorescence Microscope - now incredibly affordable

Customizable. Affordable. Easy to use.

fluorescence microscopes
View product
Show all internal medicine
Haven't found the right news yet?

The bionity.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 0 life science news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now